IA

Iftequar Ali Ahsan Ali Syed

Active Director Managing Director DIN 09249022
DIN 09249022 First appointment Jul 2021 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Iftequar Ali Ahsan Ali Syed

Data last updated:

Iftequar Ali Ahsan Ali Syed is a Managing Director at Pharmalink Pharmaceuticals Private Limited (since 2021). The company operates in Trading.

DIN 09249022
Primary Designation Managing Director
Industry Trading
First Appointment 22 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director22 Jul 20212021Active

Board colleagues of Iftequar Ali Ahsan Ali Syed

NameDINCompanyDesignation
Mubeen Fatima Ali09249163Pharmalink Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pharmalink Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Iftequar Ali Ahsan Ali Syed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Iftequar Ali Ahsan Ali Syed

Iftequar Ali Ahsan Ali Syed currently holds 1 directorship: Pharmalink Pharmaceuticals Private Limited (Managing Director, since 22 Jul 2021).

Iftequar Ali Ahsan Ali Syed was first appointed on 22 Jul 2021 as Managing Director at Pharmalink Pharmaceuticals Private Limited.

The current boards of Iftequar Ali Ahsan Ali Syed's companies include Mubeen Fatima Ali (Pharmalink Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available